Headache Clinical Trials

Find Headache Clinical Trials Near You

Headache Ear Auditory Dizziness Sinus (HEADS) Registry

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The Headache, Ear, Auditory, Dizziness, Sinus (HEADS) Registry is a study over time of individuals living in the United States who experience sinus, vestibular, auditory, and headache symptoms. Through an online portal, participants are asked questions about their symptoms, how they have affected their lives, and how effectively they have managed them. This information is then used to better understand these symptoms and to improve patient diagnosis and treatment. Some potential research benefits of the HEADS Registry include: * Improving healthcare professionals' understanding of the causes of specific head and neck symptoms. * Reducing delays in diagnosis and the use of inappropriate tests, medications, and surgeries. * Finding the most effective treatments for sinus, vestibular, and auditory disorders. * Providing participants the opportunity to be contacted for additional important research related to sinus, vestibular, and auditory disorders. All U.S. residents over the age of majority who experience sinus, vestibular, and auditory symptoms, with or without migraine, are eligible to participate. Enrollment is voluntary, confidential, and free of charge.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Resident of the United States of America

• Age of Majority (18+ in 47 states and Washington, D.C., 19+ in Alabama and Nebraska, 21+ in Puerto Rico and Mississippi)

• Fluent in English OR Spanish.

• Experience sinus, vestibular auditory, and/or headache symptoms, with and without diagnosis of migraine.

Locations
United States
Rhode Island
Association of Migraine Disorders
RECRUITING
North Kingstown
Contact Information
Primary
Frederick Godley, MD
registry@migrainedisorders.org
(401) 379-0466
Time Frame
Start Date: 2023-07-06
Estimated Completion Date: 2033-12-31
Participants
Target number of participants: 10000
Related Therapeutic Areas
Sponsors
Collaborators: Pfizer, Lumiio Inc.
Leads: Association of Migraine Disorders

This content was sourced from clinicaltrials.gov